功能性核酸纳米结构用于线粒体向:定制治疗策略的基础
Wanchong He1, Siyu Dong1, Qinghua Zeng1
1School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.
Molecules (Basel, Switzerland)
|March 13, 2025
概括
功能性核酸 (FNA) 纳米结构正在开发中,用于线粒体特定的成像和癌症治疗. 本综述强调了用于实时线粒体分子检测的FNA生物传感器以及用于向癌症治疗的FNA纳米设备.
科学领域:
- 生物化学 生物化学
- 纳米技术 纳米技术
- 分子生物学分子生物学
背景情况:
- 线粒体是细胞研究和生物医学应用中的关键器官.
- 功能性核酸 (FNA) 纳米结构在各种生物领域显示出前景.
- 使用FNA纳米结构的线粒体应用的有针对性的战略是有限的.
研究的目的:
- 审查FNA纳米结构在线粒体特异性分子成像的最新进展.
- 探索FNA纳米结构在线粒体向癌症治疗中的使用.
- 讨论线粒体FNA纳米技术的化学原理和未来方向.
主要方法:
- 对线粒体应用的FNA纳米结构的文献综述.
- 探索基于FNA的生物传感器,用于线粒体分子检测.
- 对FNA纳米设备进行针对性癌症治疗和线粒体破坏的检查.
主要成果:
- 开发基于FNA的生物传感器,用于实时可视化线粒体分子.
- 模块化FNA纳米设备的设计,用于精确地将治疗剂输送到线粒体.
- 创建可编程的FNA纳米结构来破坏癌症治疗的线粒体过程.
结论:
- FNA纳米结构为线粒体特异成像和癌症治疗提供了新的工具.
- 化学设计原理的阐明是推动线粒体FNA纳米技术的关键.
- 需要进一步的研究来克服挑战,并为学术和临床使用开发复杂的FNA工具.
相关概念视频
Electron Transport Chain: Complex I and II
9.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.9K
Animal Mitochondrial Genetics
7.4K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


